arrow
W

Wendy Stock

university of chicago medical center
H指数:77
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reduced-dose pegylated asparaginase reliably achieves therapeutic levels in adult patients with acute lymphoblastic leukaemia and lymphoblastic lymphoma

减量聚乙二醇化天冬酰胺酶在成人急性淋巴细胞白血病和淋巴母细胞淋巴瘤患者中可靠地达到治疗水平

2026-10-180
OAAI
Association of sarcopenia with treatment tolerance in older adults with acute myeloid leukemia using artificial intelligence computed tomography–segmentation and a geriatric assessment
Leukemia
IF13.4
2026-08-310
OAAI
Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia

BRAF突变在急性髓系白血病中的预后和治疗意义

Leukemia
IF13.4
2026-06-150
OAAI
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia

靶向凋亡的BH3拟似物:改变急性髓系白血病患者的治疗方法

2025-09-010
PRE
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia

社会决定因素对成人复发/难治性B细胞急性淋巴细胞白血病患者brexucabtagene autoleucel治疗结局的影响

2025-08-230
OAAI
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults

成人TP53突变急性淋巴细胞白血病的临床与分子特征

2025-08-140
OAAI
Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features

B细胞急性淋巴细胞白血病的多能谱系潜能与特定的细胞起源和临床特征相关。

2025-06-270
PRE
Guideline-concordant treatment among adolescents and young adults with acute lymphoblastic leukemia

指南一致治疗在青少年和年轻急性淋巴细胞白血病患者中的应用

2025-06-010
OAAI
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

新诊断急性髓系白血病60岁及以上患者的分子特征分析:Beat AML临床试验报告

2025-04-030
OA
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study
CANCER
IF5.1
2025-02-061
OAAI
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia

Asciminib 联合达沙替尼和泼尼松治疗费城染色体阳性急性白血病

BLOOD
IF23.1
2025-02-062
PRE
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL
2024-12-102
OAAI
Interim Results of a Phase II Study Investigating Dasatinib and Inotuzumab Ozogamicin-Based Induction for Newly-Diagnosed Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia (Ph plus ALL)

一项关于达沙替尼和伊诺妥单奥唑米星为基础诱导治疗新诊断费城染色体阳性急性淋巴细胞白血病(Ph plus ALL)的II期研究中期结果

BLOOD
IF23.1
2024-11-050
PRE
IDH2 Mutation Is Associated with Favorable Outcome Among Older Adults with Newly Diagnosed Acute Myeloid Leukemia Treated with Lower-Intensity Therapy

IDH2突变与接受低强度治疗的新诊断急性髓系白血病老年患者的良好预后相关。

BLOOD
IF23.1
2024-11-051
PRE
Targeting Menin in T-Lineage Acute Lymphoblastic Leukemia

靶向Menin在T系急性淋巴细胞白血病中的应用

BLOOD
IF23.1
2024-11-050
PRE